To further investigate whether the mRNA expression levels of HCP5 were also affected in hMOF-downregulated human ovarian cancer tissues, 28 clinically diagnosed ovarian cancer tissues were selected. The gene discussed is HCP5; the disease is ovarian carcinoma.